TPCW
RMD icon

TD Private Client Wealth’s ResMed RMD Stock Holding History

TD Private Client Wealth’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$52.5K Sell
234
-7
-3% -$1.74K ﹤0.01% 866
2025
Q4 		$58K Sell
241
-2
-0.8% -$511 ﹤0.01% 856
2025
Q3 		$66.5K Buy
243
+10
+4% +$2.73K ﹤0.01% 814
2025
Q2 		$60.1K Sell
233
-31
-12% -$7.39K ﹤0.01% 815
2025
Q1 		$59.1K Sell
264
-31
-11% -$7.24K ﹤0.01% 783
2024
Q4 		$67.5K Buy
295
+19
+7% +$4.58K ﹤0.01% 772
2024
Q3 		$67.4K Buy
276
+32
+13% +$7.15K ﹤0.01% 779
2024
Q2 		$46.7K Sell
244
-149
-38% -$30.2K ﹤0.01% 818
2024
Q1 		$77.8K Sell
393
-15
-4% -$2.75K ﹤0.01% 732
2023
Q4 		$70.2K Buy
408
+51
+14% +$7.84K ﹤0.01% 755
2023
Q3 		$52.8K Buy
357
+10
+3% +$1.81K ﹤0.01% 764
2023
Q2 		$75.8K Sell
347
-23
-6% -$5.13K ﹤0.01% 705
2023
Q1 		$81K Buy
370
+27
+8% +$5.86K ﹤0.01% 682
2022
Q4 		$71.4K Sell
343
-25
-7% -$5.49K ﹤0.01% 673
2022
Q3 		$80.3K Buy
368
+16
+5% +$3.64K ﹤0.01% 647
2022
Q2 		$73.8K Sell
352
-43
-11% -$9.15K ﹤0.01% 653
2022
Q1 		$95.8K Buy
395
+8
+2% +$1.94K ﹤0.01% 645
2021
Q4 		$101K Sell
387
-15
-4% -$3.89K ﹤0.01% 637
2021
Q3 		$106K Buy
402
+26
+7% +$7.11K ﹤0.01% 628
2021
Q2 		$92.7K Buy
376
+54
+17% +$11.4K ﹤0.01% 627
2021
Q1 		$62.5K Sell
322
-202
-39% -$40.5K ﹤0.01% 673
2020
Q4 		$111K Buy
524
+12
+2% +$2.39K 0.01% 545
2020
Q3 		$87.8K Buy
512
+16
+3% +$2.96K ﹤0.01% 542
2020
Q2 		$95.2K Buy
496
+161
+48% +$26.3K 0.01% 526
2020
Q1 		$49.3K Buy
335
+39
+13% +$6.21K ﹤0.01% 581
2019
Q4 		$45.9K Buy
+296
New +$42.7K ﹤0.01% 622

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TD Private Client Wealth's RMD Position: Q1 2026 in Review

TD Private Client Wealth reduced its ResMed (RMD) stake by 2.9% in Q1 2026, selling an estimated $1.74K and leaving 234 shares worth $52.5K. The position accounts for ﹤0.01% of the portfolio, ranked #866.

TD Private Client Wealth first reported a position in RMD in Q4 2019 and has held it in 26 quarters since. The position peaked at $111K in Q4 2020. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • TD Private Client Wealth held 234 shares of ResMed worth $52.5K as of Q1 2026.
  • TD Private Client Wealth sold 7 ResMed shares in Q1 2026, an estimated $1.74K.
  • ResMed made up ﹤0.01% of TD Private Client Wealth's portfolio in Q1 2026, its #866 holding.
  • TD Private Client Wealth first reported a position in ResMed in Q4 2019 and has held it in 26 quarters since.
  • TD Private Client Wealth's ResMed position peaked at $111K in Q4 2020.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on TD Private Client Wealth's 13F filing for Q1 2026, filed 27 Apr 2026.